Effect of Cocoa and Theobromine Consumption on Serum HDL-cholesterol Concentrations: a Randomized Controlled Trial
Overview
Affiliations
Background: Evidence from clinical studies has suggested that cocoa may increase high-density lipoprotein (HDL)-cholesterol concentrations. However, it is unclear whether this effect is attributable to flavonoids or theobromine, both of which are major cocoa components.
Objectives: We investigated whether pure theobromine increases serum HDL cholesterol and whether there is an interaction effect between theobromine and cocoa.
Design: The study had a 2-center, double-blind, randomized, placebo-controlled, full factorial parallel design. After a 2-wk run-in period, 152 healthy men and women (aged 40-70 y) were randomly allocated to consume one 200-mL drink/d for 4 wk that contained 1) cocoa, which naturally provided 150 mg theobromine and 325 mg flavonoids [cocoa intervention (CC)], 2) 850 mg pure theobromine [theobromine intervention (TB)], 3) cocoa and added theobromine, which provided 1000 mg theobromine and 325 mg flavonoids [theobromine and cocoa intervention (TB+CC)], or 4) neither cocoa nor theobromine (placebo). Blood lipids and apolipoproteins were measured at the start and end of interventions.
Results: In a 2-factor analysis, there was a significant main effect of the TB (P < 0.0001) but not CC (P = 0.1288) on HDL cholesterol but no significant interaction (P = 0.3735). The TB increased HDL-cholesterol concentrations by 0.16 mmol/L (P < 0.0001). Furthermore, there was a significant main effect of the TB on increasing apolipoprotein A-I (P < 0.0001) and decreasing apolipoprotein B and LDL-cholesterol concentrations (P < 0.02).
Conclusions: Theobromine independently increased serum HDL-cholesterol concentrations by 0.16 mmol/L. The lack of significant cocoa and interaction effects suggested that theobromine may be the main ingredient responsible for the HDL cholesterol-raising effect. This trial was registered at clinicaltrials.gov as NCT01481389.
Weigant J, Afchar A, Barzen M, Dicks L, Zimmermann B, Schmid M Mol Nutr Food Res. 2025; 69(5):e202400490.
PMID: 39901369 PMC: 11874242. DOI: 10.1002/mnfr.202400490.
Flavan-3-ols and Vascular Health: Clinical Evidence and Mechanisms of Action.
Godos J, Romano G, Laudani S, Gozzo L, Guerrera I, Dominguez Azpiroz I Nutrients. 2024; 16(15).
PMID: 39125353 PMC: 11313926. DOI: 10.3390/nu16152471.
Arisi T, da Silva D, Stein E, Weschenfelder C, de Oliveira P, Marcadenti A Nutrients. 2024; 16(12).
PMID: 38931273 PMC: 11206597. DOI: 10.3390/nu16121919.
Exploring the association between theobromine intake and hepatic steatosis in young people.
Kong Y, Han L, Zhu Z, Chen X Sci Rep. 2024; 14(1):12922.
PMID: 38839921 PMC: 11153625. DOI: 10.1038/s41598-024-63863-6.
Gonzales-Yepez K, Vilela J, Reategui O Int J Food Sci. 2023; 2023:4323645.
PMID: 36654718 PMC: 9842410. DOI: 10.1155/2023/4323645.